Valmark Advisers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Buy |
2,190
+2
| +0.1% | +$1.12K | 0.01% | 343 |
|
|
2026
Q1 | $1.23M | Buy |
2,188
+260
| +13% | +$167K | 0.01% | 319 |
|
|
2025
Q4 | $1.3M | Hold |
1,928
| – | – | 0.02% | 308 |
|
|
2025
Q3 | $1.23M | Sell |
1,928
-60
| -3% | -$36.4K | 0.02% | 301 |
|
|
2025
Q2 | $1.07M | Sell |
1,988
-5
| -0.3% | -$2.39K | 0.01% | 320 |
|
|
2025
Q1 | $837K | Hold |
1,993
| – | – | 0.01% | 340 |
|
|
2024
Q4 | $824K | Buy |
1,993
+2
| +0.1% | +$877 | 0.01% | 339 |
|
|
2024
Q3 | $1.01M | Sell |
1,991
-8
| -0.4% | -$3.89K | 0.02% | 303 |
|
|
2024
Q2 | $974K | Buy |
1,999
+39
| +2% | +$19.6K | 0.02% | 291 |
|
|
2024
Q1 | $1.06M | Hold |
1,960
| – | – | 0.02% | 260 |
|
|
2023
Q4 | $1.09M | Sell |
1,960
-22
| -1% | -$10.3K | 0.02% | 238 |
|
|
2023
Q3 | $867K | Sell |
1,982
-33
| -2% | -$16.5K | 0.02% | 243 |
|
|
2023
Q2 | $1.01M | Sell |
2,015
-1
| -0% | -$479 | 0.02% | 228 |
|
|
2023
Q1 | $1.01M | Buy |
2,016
+1
| +0% | +$479 | 0.02% | 221 |
|
|
2022
Q4 | $822K | Buy |
2,015
+900
| +81% | +$349K | 0.02% | 238 |
|
|
2022
Q3 | $363K | Hold |
1,115
| – | – | 0.01% | 322 |
|
|
2022
Q2 | $391K | Hold |
1,115
| – | – | 0.01% | 319 |
|
|
2022
Q1 | $610K | Hold |
1,115
| – | – | 0.01% | 277 |
|
|
2021
Q4 | $734K | Hold |
1,115
| – | – | 0.01% | 233 |
|
|
2021
Q3 | $693K | Sell |
1,115
-21
| -2% | -$14.1K | 0.01% | 240 |
|
|
2021
Q2 | $717K | Sell |
1,136
-18
| -2% | -$9.94K | 0.01% | 234 |
|
|
2021
Q1 | $565K | Sell |
1,154
-5
| -0.4% | -$2.5K | 0.01% | 257 |
|
|
2020
Q4 | $579K | Sell |
1,159
-31
| -3% | -$13.9K | 0.01% | 240 |
|
|
2020
Q3 | $468K | Buy |
1,190
+5
| +0.4% | +$1.85K | 0.01% | 186 |
|
|
2020
Q2 | $391K | Hold |
1,185
| – | – | 0.01% | 188 |
|
|
2020
Q1 | $287K | Hold |
1,185
| – | – | 0.01% | 184 |
|
|
2019
Q4 | $309K | Hold |
1,185
| – | – | 0.01% | 191 |
|
|
2019
Q3 | $322K | Sell |
1,185
-1,180
| -50% | -$328K | 0.01% | 183 |
|
|
2019
Q2 | $651K | Hold |
2,365
| – | – | 0.01% | 122 |
|
|
2019
Q1 | $529K | Hold |
2,365
| – | – | 0.01% | 135 |
|
|
2018
Q4 | $440K | Hold |
2,365
| – | – | 0.01% | 134 |
|
|
2018
Q3 | $590K | Hold |
2,365
| – | – | 0.01% | 117 |
|
|
2018
Q2 | $515K | Hold |
2,365
| – | – | 0.01% | 119 |
|
|
2018
Q1 | $453K | Hold |
2,365
| – | – | 0.01% | 117 |
|
|
2017
Q4 | $370K | Buy |
+2,365
| New | +$372K | 0.01% | 129 |
|
Other funds holding IDXX
Valmark Advisers's IDXX Position: Q2 2026 in Review
Valmark Advisers increased its Idexx Laboratories (IDXX) stake by 0.09% in Q2 2026, buying an estimated $1.12K and bringing the position to 2,190 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #343.
Valmark Advisers first reported a position in IDXX in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.3M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Valmark Advisers held 2,190 shares of Idexx Laboratories worth $1.15M as of Q2 2026.
- Valmark Advisers bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
- Idexx Laboratories made up 0.01% of Valmark Advisers's portfolio in Q2 2026, its #343 holding.
- Valmark Advisers first reported a position in Idexx Laboratories in Q4 2017 and has held it in 35 quarters since.
- Valmark Advisers's Idexx Laboratories position peaked at $1.3M in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.